Dilafor AB is a Swedish drug development company focusing on the development of tafoxiparin for obstetric indications.

Pharmaceutical

Life Sciences

Dilafor

Lena Degling Wikingsson

Ann-Sofie Sternås

Per-Olov Eriksson

Per Blom

Gunvor Ekman-Ordeberg

Torsten Goesch

Viktor Drvota

Raffaele Caldarone

Enrica Bovina

Fredrik Ahlström

Johan Rasin

At Dilafor, the Directors and Heads team is responsible for overseeing various crucial aspects of the company's operations. This includes manufacturing processes, intellectual property management, quality assurance in compliance with Good Manufacturing Practices (GMP), and providing strategic direction to ensure the successful development of tafoxiparin for obstetric indications.

Directors and Heads

The Clinical and Safety Team at Dilafor AB is responsible for overseeing the clinical trials and ensuring the safety of tafoxiparin for obstetric indications. This team manages clinical operations, evaluates safety data, and assesses non-clinical safety and toxicology to ensure compliance with regulatory standards and to safeguard patient health.

Clinical and Safety Team

The Leadership Team at Dilafor AB is responsible for defining the strategic direction of the company and overseeing the development of tafoxiparin for obstetric indications. This team collaborates on critical decisions related to drug development, operational efficiency, and regulatory compliance, while also ensuring alignment with the company's mission to improve maternal health outcomes. With a focus on innovation and patient safety, they guide the organization toward successful clinical trials and market entry.

Leadership Team

Dilafor

Org chart

Board & advisors

Teams

Directors and Heads

Clinical and Safety Team

Leadership Team

Offices

Dilafor

Org chart

Board & advisors

Teams

Directors and Heads

Clinical and Safety Team

Leadership Team

Offices

Related companies